Correlation Between AN2 Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on AN2 Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Pasithea Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Pasithea is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AN2 Therapeutics is 1.02 times less risky than Pasithea Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 652.00 in Pasithea Therapeutics Corp on August 26, 2024 and sell it today you would lose (342.00) from holding Pasithea Therapeutics Corp or give up 52.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
AN2 Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| AN2 Therapeutics |
| Pasithea Therapeutics |
AN2 Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |